chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen axillary lymph nodes for 2+ weeks; Low energy; Tender arm; This is a spontaneous report from a contactable Health Care Professional (patient). A 30-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route, administered in Arm Left on 22Jan2021 at 13:15 PM (age of 30-year-old at vaccination) as a 1ST DOSE, SINGLE for COVID-19 immunization. The patient's medical history and known allergies were reported as none. The patient's concomitant medications included collagen, ibuprofen and ascorbic acid/biotin/calcium pantothenate/cyanocobalamin/folic acid/nicotinic acid/pyridoxine hydrochloride/riboflavin/thiamine hydrochloride/tocopheryl acetate (MULTIVITAMIN). The patient did not have Covid-19 prior to vaccination. The patient was Vaccinated at  facility. The patient was not on any other vaccine 4 weeks prior to Covid-19 vaccination. On 24Jan2021 at 08:30 AM, the patient experienced swollen axillary lymph nodes for 2 plus weeks, low energy, tender arm. The patient was not tested for Covid-19 post vaccination. The patient had visited physician office. It was unknown if patient received treatment medication for the resulted events. The outcome of the event swollen axillary lymph nodes was recovered on any unknown date in 2021 and outcome of other events was unknown.  This follow-up was being submitted to notify that the lot/batch number was not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information was expected.
Elevated heart rate ~20bpm higher resting heart rate  (~10 hrs after injection) Fever ~101F  (~27 hrs after injection) Nausea (~27 hrs after injection) Headache (~18 hrs after injection) Muscle soreness (~10 hrs after injection) Injection site soreness (4-5 hrs after injection) Tiredness  (~10 hrs after injection)  Most symptoms dissipated roughly 34hrs after injection. If not gone severity greatly reduced.
Arm was painful red and hot. Area of erythema from should to elbow, mostly distal to vaccine site.  Symptoms lasted 5 days.
This spontaneous report as received from a pharmacist refers to a 31 year old female patient. On approximately 13-AUG-2012 (also reported as a year and a half ago) the patient was vaccinated with first dose of GARDASIL (lot number and expiry date unknown) (dosing regimen and frequency unknown). No adverse events were reported. No product quality issue was reported. Additional information has been requested.
SWELLING AT SIGHT OF IMMUNIZATION. REDNESS AND HEAT. PATIENT SAID ARM FELT HEAVY. PATIENT FELT HOT.
Nausea, headache lasting through next day (02/22/2015) subsiding next day (02/23/2015).
Tongue felt burnt & rough, onset day after vaccine & lasted ~ 8hrs. Reported moodiness & brain fog
Approximately 2 hours after shot both ears started ringing very loudly... it was instantaneous... walking across floor and "click" the ringing started
Client got pneumonia shot on 10/23/2001 and right arm swelled, redness and pain.
got bothshots.This is 3rd break out/Suspected vaccination failure; Shingles/ 3rd time since the vaccines i have broke out. First 2; this time they hurt; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 14-Nov-2022 Reporter' s comment: The case was received from the patient via interactive digital media. The patient had got both the vaccines this year and this was the 3rd time since the vaccines, he/she broke out. The first 2 times were not bad but this time they hurt. The patient stated that so much for the vaccines for him/her. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
I started experiencing about 2 mins. after receiving the vaccine I started having difficulty breathing. I did not tell Pharmacy, I told my husbands since he is a doctor. I wheezing, very tight it got a little better but I am still not breathing the way I normally do, feels heavy.  Better but not gone.  I call the allergist and talked to him but did not go in. I started using an inhaler and inhaling steroids and trying to loosen things up with Allegra D along with deep breathing exercises to try to open up.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The pertinent medical history and concomitant medication was not reported. On 11-JUN-2015, the patient was vaccinated with unspecified number of improperly stored doses of MMR II (lot: K004949 and Expiry: 04-APR-2016) (route unspecified). No adverse effects was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 74-year-old female patient who received SHINGRIX for prophylaxis. On 20th December 2018, the patient received the 1st dose of SHINGRIX. On 20th December 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain, injection site swelling and injection site bruising. On 21st December 2018, the patient experienced injection site rash and injection site discoloration. On an unknown date, the outcome of the injection site pain, injection site swelling, injection site bruising, injection site rash and injection site discoloration were recovered/resolved. It was unknown if the reporter considered the injection site pain, injection site swelling, injection site bruising, injection site rash and injection site discoloration to be related to SHINGRIX. Additional details were reported as follows: The caller was the patient herself. The patient received SHINGRIX on left arm. The patient experienced swollen arm, bruising and pain at the injection site. The swollen arm lasted for over a week, the bruising lasted for 3 weeks, and pain at injection site lasted for about three to four days. Day after the vaccination she experienced a pink rash at the injection in the front side of the arm which lasted for about 5 days. The reporter did not give consent to follow up. No further details provided. This case has been linked with US2019013627, reported by same reporter.
Started having a rough dry cough on 6/24/2022 then did a home test that immediately showed positive that evening. Took paclovid for 5 days starting 6/25/2022. Had a rebound/shedding that started on 07/11/2022 and ran through 07/18/2022. I did not notice that the rebound event was happening other than testing positive for Covid19 again on home test kits.
Patient had an approximate 30 second seizure like activity  less than 24 hours post vaccine, followed by multiple brief seizure like events over a period of 1.5 hours.. He was afebrile. He was admitted overnight to the hospital.
I was encouraged by a physician to report this interesting adverse event. I was diagnosed via rapid test with COVID-19 on June 29 and immediately began a course of Paxlovid. My symptoms were clear and I tested negative on day 5 after infection. On July 6th I received the Jynneos vaccine for monkeypox; I began feeling standard side effects the next day on July 7th. Shortly afterward, I experienced a "rebound" infection of COVID-19 which is ongoing; I suspect that the vaccination may have played a role in the rebound.
Exp date on vaccine was 10/28/22 and given on 10/31/22.  Error not discovered until vaccine given
DIZZINESS; UPSET STOMACH; ANXIETY ATTACK; MALAISE; CHILLS; EXHAUSTED; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch number. No concomitant medications were reported. On an unspecified date, the subject experienced dizziness, upset stomach, anxiety attack, malaise, chills, and exhausted. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, upset stomach, anxiety attack, malaise, chills, and exhausted. This report was non-serious.
Right after the needle came out a lot of blood came out; Possible that some of the vaccine came out with the blood; Maybe he hit an artery, a blood vessel; This case was reported by a pharmacist via call center representative and described the occurrence of injection site hemorrhage in a female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2020-2021 season) for prophylaxis.   On 8th October 2020, the patient received Fluarix Quadrivalent 2020-2021 season. On 8th October 2020, immediately after receiving Fluarix Quadrivalent 2020-2021 season, the patient experienced injection site hemorrhage, accidental underdose and wrong injection technique. On an unknown date, the outcome of the injection site hemorrhage, accidental underdose and wrong injection technique were unknown.   It was unknown if the reporter considered the injection site hemorrhage to be related to Fluarix Quadrivalent 2020-2021 season.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Fluarix vaccination and right after the needle came out a lot of blood came out. The reporter stated that maybe he hit an artery, a blood vessel. The reporter consented to follow up. No data regarding the patient or vaccine administered were provided as reporter stated not being at the facility at the time of reporting. Upon escalation to second line specialist, the reporter asked about validity of dose of Fluarix since he was not sure but it was possible that some of the vaccine came out with the blood, which led to accidental underdose.
Pain 5 out of 10 upper R arm. Burning sensation from the injection site to my fingertips x24 hours. Skin cold to the touch even with attempts to warm with hot compresses x24 hrs.
Hives over arm, face and swelling/itching. Treated with Benadryl 50mg PO.
Patient complaint of shortness of breath, and difficulty sleeping. Improved by next am. Large local to upper arm extending to lower measuring approximately 7 by 10 inches.
About one hour after receiving the vaccine I experienced itching and mild hives. I am still itching 3 days later, but I do have other allergies and am not sure if this itching is from the vaccine or not. The hives are gone.  An hour and a half after receiving the vaccine, around 5 p.m., I experienced extreme dizziness for a brief moment, 30 seconds? It took my breath away; it was frightening as I have had 2 strokes in the past.
got the fever today; chills in the morning; This is a spontaneous report from a contactable consumer (reported for herself) via medical information team.  A 38-year-old-female patient received first dose of BNT162B2 (Pfizer covid-19 vaccine, solution for injection, Lot number and Expiration date: Not reported) via an unspecified route of administration as a single dose on an unknown date, for Covid-19 immunization. Medical history and concomitant medications were not reported. On 21Apr2021 (the day of this report), she experienced fever. She had the chills in the morning. It was stated that she had like a 100.4 degree F and recently when she checked out it was 100.6 degree F. The outcome of the events of fever and chills unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
About 9 hours after vaccine, developed body aches and rigors, low grade temp to ~100.   Fatigued, so went to bed and took ibuprofen.  Continued to have significant body aches and rigors.  While lying in bed, developed nausea.  I got up to go to the bathroom and woke up on the bathroom floor after a syncopal episode.  I returned to bed bed and still felt very lightheaded and laid down.  I had another brief syncopal episode while lying down.  I felt short of breath and had chest tightness when I woke up.  This was around 11pm.  I was evaluated in the ED, where I continued to have body aches and rigors.  I developed fever to 101 and was given Advil and Tylenol as well as IVF.  Symptoms finally resolved.  Had COVID test (which was negative), CBC, chemistries, EKG, chest x-ray, all of which were negative/normal.  Continued to feel significantly fatigued for an additional 48 hours.
Aproximately 30 minutes after injection, I felt stimulated as if having drank too many energy drinks, mild diaphoresis, mild trembling, racing heart rate.  Suffered uncharateristic insomnia the same night.  On 2/23/21, I awoke after 6 hours sleep, with mild body aches and general torpor -malaise.  This progressed into the early afternoon to severe body aches 8/10 on pain scale of 10, a moderate headache of 3/10, excessive drowsiness, extreme diaphoresis, chills, and a temperature spike of 1 degree.  I had very mild motor trembling in upper extremeties (hands) that seemed unassociated with fever.  I took no medications and slept under these general conditions for 80% of the next 48 hours.  The headache did reduce after the 10 hours from onset.
Report form school-based health provider that patient woke up the next morning with a head-to-toe, fine papular rash with uticaria. No new detergents, foods, or medications, mostly resolved as of 3/29/18.
Information has been received from a registered nurse concerning an 18 year old female who on 13-JUL-2007 was vaccinated with a first dose of Gardasil (lot# unknown) IM at 2:30PM. Concomitant therapy also given on 13-JUL-2007 included Vaqta (duration and dose not reported) and Menactra. Other concomitant therapy included cetirizine hydrochloride (+) pseudoephedrine hydrochloride (ZYRTEC-D). On 14-JUL-2007 at 11:30 PM the patient experienced a generalized tonic-clonic seizure at which time she was admitted to the ER. Several tests were performed including a magnetic resonance imaging (MRI) and a computed axial tomography (CT) test and drug test which were negative. An electroencephalography (EEG) test was also performed which showed minimal abnormalities. There was no family history of seizures and the patient herself had never had a seizure. The patient also had a headache that rated 7 out of 10 . The patient was treated with lorazepam (ATIVAN), which they believe aborted another possible seizure. It was also reported that the patient was on vacation one week before vaccination on a cruise in the Caribbean. At the time of reporting the patient was recovering. Upon internal review generalized clonic-tonic seizure is considered to be an other important medical event. Additional information has been requested.
Immediately after injection patient began complaining of dizziness. VS WNL. After 15 minutes of sitting, patient got up to walk out and reported difficulty walking. Monitored patient another 15 minutes and symptoms resolved.
Pt vaccinated with DTP/OPV developed prolonged seizure assoicated also w/fever & bilat otitis media. No treatment.
A very itchy rash which looked like shingles about 5 inches in diameter appeared under my right arm close to my breast on Sat.  About 30 mins. later it began to look like large welts.  About 30 mins. after that it disappeared leaving raised skin.  The raised skin went away in about 30 mins.
headaches; This is a spontaneous report received from a contactable consumer from medical information team.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headaches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient reported feeling "not too lucid" the day after the injection and called the emergency squad, he was taken to the hospital and was evaluated by physician who stated in discharge report: "91 year-old male who presents with cough fever and fatigue for 2-3 days and notably received the COVID vaccination 1 day prior. CXR with possible early PNA of left lung. Fever curve improved, symptoms improving, on room air, no leukocytosis. COVID negative. Overall, appeared to be improving but was observed closely due to age. Suspect fever may be related to COVID vaccine but difficult to know for sure giving imaging appearance however does not otherwise appear systemically ill. He received treatment with ceftriaxone and azithromycin inpatient and monitored and then narrowed to PO to complete 5 day total course with 3 remaining days of amoxicillin +azithromycin. Home health referral was made and set up on discharge." Physician completing report is local Dr. from local health care facility.
This spontaneous report as received from a healthcare worker, refers to an unspecified number of patients of unknown age and gender. On unspecified dates since 02-JAN-2015, the patients were administered an unspecified number of improperly stored doses of PROQUAD (lot # K023364, expiration date was not provided) dose and route were not reported. This is one of several reports received from the same source. Additional information has been requested.
The pain is in the anterior aspect of her bilateral legs right> left. Of note, pt did have some left sided axillary LAD that started 5 days post vaccine and resolved spontaneously 3 days later. Pt also has some tenderness in the extensor surface of her right arm. Denies overlying skin changes.
Severe headache from neck to eyebrows. Chills, running 104.4 temp muscle cramps in legs, extremely tired
Fatigue, 48 hours later; Fever, lasted 3 days; Chills, 12 hours later; Headache, 12 hours later; Soreness in the injection arm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Soreness in the injection arm), PYREXIA (Fever, lasted 3 days), CHILLS (Chills, 12 hours later), HEADACHE (Headache, 12 hours later) and FATIGUE (Fatigue, 48 hours later) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020.    On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Dec-2020, the patient experienced VACCINATION SITE PAIN (Soreness in the injection arm). On 28-Dec-2020, the patient experienced PYREXIA (Fever, lasted 3 days). 28-Dec-2020, the patient experienced CHILLS (Chills, 12 hours later) and HEADACHE (Headache, 12 hours later). On 29-Dec-2020, the patient experienced FATIGUE (Fatigue, 48 hours later). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Soreness in the injection arm), PYREXIA (Fever, lasted 3 days), CHILLS (Chills, 12 hours later), HEADACHE (Headache, 12 hours later) and FATIGUE (Fatigue, 48 hours later) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, SARS-CoV-2 test: positive Positive. On 27-Dec-2020, Body temperature: 102.5 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Severe redness / swelling at site. Very painful. Patient contacted her physician & MD stated probably hit a bld vessel. Pt being treated with prednisone.
Agression, severe mood swings, memory loss (developemental regression), complete change in appetite, weight loss, speech regression.
Information has been received from a registered nurse concerning an 8 year old white female who on 13-AUG-2007 was vaccinated SC on left arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot # 657649/0815U). There was no illness at the time of vaccination. On approximately 13-AUG-2007, immediately after vaccination the patient experienced hard welt, red and hot to touch. It was reported that on 16-AUG-2007 the patient recovered. No diagnostic laboratory tests were undertaken. Additional information has been requested. This is one of several reports received from the same source.
Pateint got flu every time; Initial information was received on 07-Dec-2020 regarding an unsolicited valid non-serious case from social media via consumer or non-health care professional (Patient).  This case involves patient [age and gender unspecified] who got flu every time [influenza], while patient received vaccine INFLUENZA VACCINE [Flu shot].  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacture) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got flu (influenza) (non-serious) unknown latency following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the batch number for this case.
Wheezing, crackly voice.  10/28am rash on abdomen, coughing, sneezing, resp. congestion.  Rash became blistery.  Mom states he was exposed to someone with bronchitis before receiving vaccination
chills; body aches; mild fever; This case was reported by a nurse via call center representative and described the occurrence of chills in unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced chills, general body pain and fever. On an unknown date, the outcome of the chills, general body pain and fever were recovered/resolved.   It was unknown if the reporter considered the chills, general body pain and fever to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The nurse reported that multiple patient experienced mild fever, body aches and chills after receiving the 2nd dose of Shingrix. These events occurred 24 to 48 hours after the dose was administered and resolved within 24 to 48 hours. The reporter did not consent to follow-up. This is 1 of the 4 cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020211994:same reporter US-GLAXOSMITHKLINE-US2020211991:same reporter US-GLAXOSMITHKLINE-US2020211989:same reporter